News & Articles

Chairman and CEO Albert Bourla calls on biopharma industry to collaborate on combating the global pandemic

The Standard is said to contain synthetic COVID-19 RNA transcripts and human genomic DNA

The test kit aims to differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes

IDT's primer and probe kit can be used as a component of the CDC testing protocol for the diagnosis and detection of COVID-19

The FDA has issued its fourth Emergency Use Authorization for coronavirus tests, this time to Thermo Fisher Scientific for its TaqPath COVID-19 Combo Kit

The first commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs

QIAGEN launches therascreen PIK3CA RGQ PCR Kit in Europe

Originally scheduled from March 11–15, the event has been postponed and will now take place from October 19–22, 2020

The new tubes and racks promise long-term stability and uninterrupted operation in biobanking and compound storage applications

The EDX RP Positive Run Control aims to monitor the performance of clinical respiratory assays

Incorporation of AI technologies highlights the most accurate compound predictions to enable effective project decision-making

Ultra-clean deep well and assay microplates to be showcased at the Lab Innovations 2019 exhibition

Designed specifically for smaller biobanks the BB package simplifies sample integrity, tracking and audit trail.

Innovation aims to improve productivity in the lab and enhance reliability and turnaround times in delivering results to patients

Roche's assay to be used to find patients eligible for treatment with Tecentriq in combination with Abraxane

First collaboration product includes medical imaging capabilities to enable more personalized treatment decisions in cancer care

The cobas TV/MG test promises to provide the flexibility to process up to four sexually transmitted infections from one patient sample

The VENTANA ROS1 (SP384) rabbit monoclonal primary antibody is designed to effectively identify elevated ROS1 protein expression

Abbott's AlinIQ Integrated Platform analyzes currently siloed datasets to help hospitals make more informed decisions based on their unique needs